Global pharma firms walk back innovative drug investments in Japan
We haven't written up this one. Nikkei Asia has the full story — the link below goes straight to it.
More in Health & Medicine
Extreme Plastic Surgery Makeover Show Panned in New Documentary
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics.
Dementia cases are expected to more than double by 2050. A new study reveals who’s most at risk
More and more of our loved ones could develop dementia , as the number of diagnoses is projected to more than double by 2050, according to new research.
Fast-Acting Pill Reduces Heartburn Frequency in Non-Erosive Reflux Disease
(MedPage Today) -- Patients with non-erosive reflux disease (NERD) who took once-daily tegoprazan -- a novel, fast-acting, oral potassium-competitive acid blocker (P-CAB) -- had a significant…
Catching up with Blue Shield of California CEO Mike Stuart one year in
In August 2025, Blue Shield of California named Mike Stuart as its CEO. Now, a year later, he's reflecting on months of work toward addressing affordability, member access and the patient journey.
Epic teams up with Amazon Pharmacy, Eli Lilly and Mark Cuban to launch prescription drug pricing tool
Epic is bringing pharmacy price shopping directly into the doctor's office and the prescribing workflow.
Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success
Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.